Trial to Evaluate Efficacy and Safety of Pembrolizumab and Gemcitabine in HER2-negative ABC
Clinical trial NCT03025880 · COMPLETED
Trial details
- NCT number
- NCT03025880
- Sponsor
- Spanish Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-28
- Primary completion
- 2019-06-03
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.